Symposia: Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Biological therapies, Acute Myeloid Malignancies, ALL, AML, clinical trials, adult, Translational Research, Lymphomas, Clinical Research, health outcomes research, T Cell lymphoma, pediatric, Diseases, Therapies, therapy sequence, clinical procedures, Lymphoid Malignancies, Myeloid Malignancies, Monoclonal Antibody Therapy, Technology and Procedures, Study Population, Human, Transplantation, Minimal Residual Disease
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Biological therapies, Acute Myeloid Malignancies, ALL, AML, clinical trials, adult, Translational Research, Lymphomas, Clinical Research, health outcomes research, T Cell lymphoma, pediatric, Diseases, Therapies, therapy sequence, clinical procedures, Lymphoid Malignancies, Myeloid Malignancies, Monoclonal Antibody Therapy, Technology and Procedures, Study Population, Human, Transplantation, Minimal Residual Disease
Monday, December 12, 2022: 10:30 AM-12:00 PM
243-245
(Ernest N. Morial Convention Center)
Moderators:
Rachel Phelan, MD, MPH, Medical College of Wisconsin
and
Neel Bhatt, MBBS, MPH, University of Washington
Disclosures:
Phelan: Amgen: Research Funding; bluebird bio: Other: advisory board participation.
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH